Work

Abstract 4363872: Acoramidis Improved Clinical Outcomes, Function, Quality of Life and NT-proBNP in Patients With Transthyretin Amyloid Cardiomyopathy Regardless of Atrial Fibrillation Status at Baseline

Year: 2025

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.152.suppl_3.4363872

Authors: Brett Sperry, Ahmad Masri, Martha Grogan, Deirdre Mooney, Olakunle Akinboboye, Brian Drachman, Jose Nativi-Nicolau, Masatake Kobayashi, Chris Chen, Jean-Francois Tamby, Adam Castano, Jonathan Fox, Richard Cheng, Daniel Judge, Francesco Cappelli

Institutions: Saint Luke's Hospital, University of Missouri–Kansas City, Oregon Health & Science University, Mayo Clinic, Penn Presbyterian Medical Center, Mayo Clinic in Florida, Tokyo Medical University, University of Washington, Medical University of South Carolina, Azienda Ospedaliero-Universitaria Careggi

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415799393

Cites:

Cited by: 1

Related to: